Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cytomegalovirus Infections | 7 | 2020 | 667 | 2.44 | Why? |
| Cytomegalovirus | 5 | 2020 | 600 | 1.49 | Why? |
| Amniocentesis | 1 | 2019 | 25 | 0.82 | Why? |
| Neonatal Screening | 1 | 2017 | 285 | 0.54 | Why? |
| Hearing Loss, Bilateral | 1 | 2012 | 19 | 0.51 | Why? |
| Pregnancy Complications, Infectious | 7 | 2021 | 11559 | 0.48 | Why? |
| Infectious Disease Transmission, Vertical | 4 | 2021 | 5164 | 0.37 | Why? |
| Pregnancy Trimester, First | 2 | 2020 | 366 | 0.34 | Why? |
| DNA, Viral | 2 | 2017 | 2521 | 0.33 | Why? |
| Kidney Transplantation | 7 | 2021 | 5397 | 0.32 | Why? |
| Saliva | 1 | 2017 | 4679 | 0.21 | Why? |
| Pregnancy | 9 | 2021 | 23879 | 0.21 | Why? |
| Fetus | 2 | 2021 | 484 | 0.20 | Why? |
| Aborted Fetus | 1 | 2018 | 34 | 0.19 | Why? |
| Job Syndrome | 1 | 2018 | 15 | 0.19 | Why? |
| Arteries | 1 | 2021 | 283 | 0.18 | Why? |
| Coxsackievirus Infections | 1 | 2017 | 71 | 0.17 | Why? |
| Fetal Diseases | 1 | 2019 | 182 | 0.17 | Why? |
| Adenovirus Infections, Human | 1 | 2018 | 145 | 0.16 | Why? |
| Paris | 4 | 2021 | 1287 | 0.16 | Why? |
| STAT3 Transcription Factor | 1 | 2018 | 268 | 0.16 | Why? |
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 6653 | 0.16 | Why? |
| Everolimus | 1 | 2018 | 215 | 0.15 | Why? |
| Edema | 1 | 2017 | 333 | 0.14 | Why? |
| Placenta | 2 | 2021 | 1531 | 0.13 | Why? |
| Polymerase Chain Reaction | 4 | 2017 | 6740 | 0.12 | Why? |
| Immunocompromised Host | 3 | 2021 | 5150 | 0.12 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.12 | Why? |
| Transcription Factors | 1 | 2018 | 784 | 0.12 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.12 | Why? |
| Transplant Recipients | 4 | 2021 | 4982 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.12 | Why? |
| Semen | 1 | 2017 | 550 | 0.11 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2021 | 1234 | 0.11 | Why? |
| France | 6 | 2021 | 12074 | 0.11 | Why? |
| Skin Diseases, Viral | 1 | 2017 | 436 | 0.11 | Why? |
| Abatacept | 2 | 2021 | 192 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 2 | 2021 | 2149 | 0.10 | Why? |
| CD3 Complex | 1 | 2009 | 237 | 0.09 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.09 | Why? |
| Immunoglobulins, Intravenous | 1 | 2021 | 2705 | 0.09 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.09 | Why? |
| Female | 19 | 2021 | 380317 | 0.09 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.09 | Why? |
| Infant, Newborn | 5 | 2021 | 23105 | 0.09 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2015 | 1439 | 0.08 | Why? |
| Graft Survival | 1 | 2009 | 587 | 0.08 | Why? |
| Kidney | 1 | 2021 | 3648 | 0.08 | Why? |
| Herpesvirus 4, Human | 1 | 2009 | 387 | 0.08 | Why? |
| Epstein-Barr Virus Infections | 1 | 2009 | 366 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.07 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
| Infant | 6 | 2021 | 30274 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2018 | 1920 | 0.07 | Why? |
| Humans | 28 | 2021 | 930598 | 0.07 | Why? |
| Child, Preschool | 6 | 2021 | 36283 | 0.07 | Why? |
| Respiratory Tract Infections | 3 | 2021 | 6817 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Child | 9 | 2021 | 70012 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Viral Load | 3 | 2018 | 15850 | 0.06 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.05 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Seasons | 3 | 2021 | 4071 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Constriction, Pathologic | 1 | 2021 | 212 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| Genes, Recessive | 1 | 2018 | 35 | 0.05 | Why? |
| Consanguinity | 1 | 2018 | 50 | 0.05 | Why? |
| Trophoblasts | 1 | 2021 | 237 | 0.05 | Why? |
| Graft Rejection | 2 | 2021 | 1766 | 0.05 | Why? |
| Amniotic Fluid | 1 | 2020 | 249 | 0.05 | Why? |
| Male | 15 | 2021 | 367725 | 0.05 | Why? |
| Zinc Fingers | 1 | 2018 | 109 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Exons | 1 | 2018 | 158 | 0.04 | Why? |
| Hydrocephalus | 1 | 2018 | 139 | 0.04 | Why? |
| Homozygote | 1 | 2018 | 230 | 0.04 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.04 | Why? |
| Immunosuppressive Agents | 3 | 2021 | 6331 | 0.04 | Why? |
| Respiratory Tract Diseases | 1 | 2005 | 1061 | 0.04 | Why? |
| Pedigree | 1 | 2018 | 502 | 0.04 | Why? |
| Microcephaly | 1 | 2018 | 181 | 0.04 | Why? |
| Loss of Function Mutation | 1 | 2018 | 244 | 0.04 | Why? |
| Adult | 9 | 2021 | 244371 | 0.04 | Why? |
| Parturition | 1 | 2020 | 514 | 0.04 | Why? |
| Whole Exome Sequencing | 1 | 2018 | 437 | 0.04 | Why? |
| Cell Nucleus | 1 | 2018 | 399 | 0.04 | Why? |
| Global Health | 1 | 2019 | 13911 | 0.04 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.04 | Why? |
| Parechovirus | 1 | 2015 | 48 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Respirovirus | 1 | 2015 | 122 | 0.04 | Why? |
| Gestational Age | 1 | 2020 | 1488 | 0.04 | Why? |
| Antiviral Agents | 2 | 2018 | 41703 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2018 | 557 | 0.04 | Why? |
| Human bocavirus | 1 | 2015 | 142 | 0.04 | Why? |
| Microbiological Techniques | 1 | 2017 | 232 | 0.03 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.03 | Why? |
| Proof of Concept Study | 1 | 2017 | 696 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.03 | Why? |
| Blood Chemical Analysis | 1 | 2018 | 541 | 0.03 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2021 | 846 | 0.03 | Why? |
| Gram-Positive Bacteria | 1 | 2015 | 230 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.03 | Why? |
| Acute Disease | 2 | 2017 | 6029 | 0.03 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.03 | Why? |
| Prevalence | 2 | 2012 | 25773 | 0.03 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.03 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Enterovirus | 1 | 2015 | 402 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2021 | 3776 | 0.03 | Why? |
| Respiratory Syncytial Viruses | 1 | 2015 | 612 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Recurrence | 1 | 2021 | 3675 | 0.03 | Why? |
| Gram-Negative Bacteria | 1 | 2015 | 473 | 0.03 | Why? |
| Antibodies, Monoclonal | 1 | 2009 | 8041 | 0.03 | Why? |
| Cesarean Section | 1 | 2020 | 2089 | 0.02 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.02 | Why? |
| RNA, Viral | 1 | 2017 | 32276 | 0.02 | Why? |
| Rhinovirus | 1 | 2015 | 979 | 0.02 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.02 | Why? |
| Adenoviridae | 1 | 2015 | 1151 | 0.02 | Why? |
| Palatine Tonsil | 1 | 2009 | 127 | 0.02 | Why? |
| Aged | 7 | 2021 | 215776 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.02 | Why? |
| Heart Diseases | 1 | 2005 | 3503 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.02 | Why? |
| Virus Diseases | 1 | 2005 | 3779 | 0.02 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.02 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2020 | 3803 | 0.02 | Why? |
| Placebos | 1 | 2009 | 629 | 0.02 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
| Orthomyxoviridae | 1 | 2015 | 1168 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2018 | 4758 | 0.02 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.02 | Why? |
| Virus Activation | 1 | 2009 | 480 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Flow Cytometry | 1 | 2009 | 2393 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Brazil | 1 | 2018 | 12582 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Phenotype | 1 | 2009 | 4037 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2009 | 1969 | 0.01 | Why? |
| B-Lymphocytes | 1 | 2009 | 4418 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Chronic Disease | 1 | 2005 | 5139 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.00 | Why? |
| Influenza, Human | 1 | 2005 | 10779 | 0.00 | Why? |
Leruez-Ville's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(211)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_